1 PREZCOBIX (DARUNAVIR/COBICISTAT) | 60 of 820 | 2660 prescriptions Less than 1% of all prescriptions | 900 | 320 patients 12% of all patients | < 11 | |
2 ODEFSEY (EMTRICITAB/RILPIVIRI/TENOF ALA) | 20 of 530 | 2550 prescriptions Less than 1% of all prescriptions | 1430 | 240 patients 9% of all patients | 130 patients 5% of all patients | |
3 DESCOVY (EMTRICITABINE/TENOFOV ALAFENAM) | 120 of 960 | 1690 prescriptions Less than 1% of all prescriptions | 300 | 230 patients 9% of all patients | < 11 | |
4 GENVOYA (ELVITEG/COB/EMTRI/TENOF ALAFEN) | 190 of 1070 | 1590 prescriptions Less than 1% of all prescriptions | 440 | 180 patients 7% of all patients | < 11 | |
5 TRIUMEQ (ABACAVIR/DOLUTEGRAVIR/LAMIVUDI) | 70 of 990 | 1440 prescriptions Less than 1% of all prescriptions | 930 | 160 patients 6% of all patients | < 11 | |
6 ATRIPLA (EFAVIRENZ/EMTRICIT/TENOFOVR DF) | 70 of 1050 | 650 prescriptions Less than 1% of all prescriptions | 500 | < 11 | < 11 | |
7 SULFAMETHOXAZOLE-TRIMETHOPRIM (SULFAMETHOXAZOLE/TRIMETHOPRIM) | 870 of 2,3430 | 510 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | A |
8 SYMTUZA (DARUNAVIR/COB/EMTRI/TENOF ALAF) | 10 of 90 | 470 prescriptions Less than 1% of all prescriptions | 110 | 140 patients 5% of all patients | < 11 | |
9 BIKTARVY (BICTEGRAV/EMTRICIT/TENOFOV ALA) | 200 of 480 | 390 prescriptions Less than 1% of all prescriptions | 220 | 110 patients 4% of all patients | < 11 | |
10 AZITHROMYCIN | 2120 of 3,6030 | 420 prescriptions Less than 1% of all prescriptions | | 130 patients 5% of all patients | < 11 | A |
11 JULUCA (DOLUTEGRAVIR/RILPIVIRINE) | 130 of 260 | 270 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
12 ABACAVIR-LAMIVUDINE (ABACAVIR SULFATE/LAMIVUDINE) | 130 of 420 | 260 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
13 INTELENCE (ETRAVIRINE) | 270 of 560 | 230 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
14 TIVICAY (DOLUTEGRAVIR SODIUM) | 560 of 1210 | 230 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
15 PREZISTA (DARUNAVIR ETHANOLATE) | 380 of 1100 | 200 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
16 ATOVAQUONE | 80 of 210 | 160 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
17 NORVIR (RITONAVIR) | 280 of 580 | 150 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
18 NEVIRAPINE | 80 of 170 | 130 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
19 EVOTAZ (ATAZANAVIR SULFATE/COBICISTAT) | 140 of 250 | 120 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
20 VANCOMYCIN HCL | 210 of 2080 | 540 prescriptions Less than 1% of all prescriptions | 390 | 180 patients 7% of all patients | < 11 | A |
21 DOXYCYCLINE HYCLATE | 1050 of 1,7230 | 300 prescriptions Less than 1% of all prescriptions | | 300 patients 11% of all patients | < 11 | A |
22 LINEZOLID | 90 of 150 | 120 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | A |
23 LEVOFLOXACIN | 1500 of 2,6250 | 240 prescriptions Less than 1% of all prescriptions | | 230 patients 9% of all patients | < 11 | A |
24 MEROPENEM | 60 of 490 | 330 prescriptions Less than 1% of all prescriptions | | 130 patients 5% of all patients | < 11 | A |
25 CIPROFLOXACIN HCL | 1700 of 3,3590 | 230 prescriptions Less than 1% of all prescriptions | | 230 patients 9% of all patients | < 11 | A |
26 PIPERACILLIN-TAZOBACTAM (PIPERACILLIN SODIUM/TAZOBACTAM) | 20 of 330 | 360 prescriptions Less than 1% of all prescriptions | 150 | < 11 | < 11 | A |
27 CLINDAMYCIN HCL | 410 of 3790 | 180 prescriptions Less than 1% of all prescriptions | | 170 patients 6% of all patients | < 11 | A |
28 METRONIDAZOLE | 570 of 1,2620 | 140 prescriptions Less than 1% of all prescriptions | | 140 patients 5% of all patients | < 11 | A |
29 CEFEPIME HCL | 140 of 520 | 190 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | A |
30 FLUCONAZOLE | 760 of 1,3920 | 150 prescriptions Less than 1% of all prescriptions | | 120 patients 4% of all patients | < 11 | |